FigureĀ 1.
Swimmer plot of clinical courses after tisagenlecleucel in pediatric and young adult patients with R/R BCL. Blina, blinatumomab; DLI, donor lymphocyte infusion; PD, progressive disease; Pembro, pembrolizumab; PMBCL, primary mediastinal BCL; SD, stable disease.